O

Oryzon Genomics
ORY

Last Price

Oryzon Genomics Balance Sheet

Assets
Metric2019202020212022202320242025
5.619M28.369M
1.44M2.239M
2.978K3.731K
-55.451K
1.686M-
8.748M30.667M
355.567K380.095K
97.096M109.218M
-125.518K
-4.133M
2.517M-
99.969M113.857M
--
108.716M144.524M
Liabilities
Metric2019202020212022202320242025
2.126M3.027M
803.61K533.565K
8.736M5.184M
22.699K-
--
--
0.05M7.021M
11.739M15.766M
7.386M6.735M
57.07K10.467K
--
-4.133M
2.481M0.02M
9.935M10.909M
--
21.674M26.675M
Equity
Metric2019202020212022202320242025
-2.03M-5.809M
--
3.289M3.994M
-19.289M-20.812M
100.715M132.162M
4.358M-4.087M
--
87.042M105.449M
--
87.042M105.449M
108.716M144.524M
Other
Metric2019202020212022202320242025
-140.101K
16.213M11.94M
10.595M-16.414M

Balance Sheet Composition

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.